Skip to Content

Pivotal Therapeutics Inc PVTTF

Morningstar Rating
$0.00 0.00 (179,900.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PVTTF is trading at a 27% discount.
Price
$0.00
Fair Value
$3.58
Uncertainty
Extreme
1-Star Price
$7.17
5-Star Price
$1.18
Economic Moat
Kjzcgy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PVTTF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.04
Market Cap
$172,429.98
Volume/Avg
56,000 / 31,633

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pivotal Therapeutics Inc is a Canada based pharmaceutical company. It focuses on Omega-3 therapies for cardiovascular disease and overall health. The products of the company are VASCAZEN which is a prescription-only medical food for the treatment of an Omega-3 Deficiency in patients with cardiovascular disease, OMAZEN, and BENEFISHIAL which provides pure Omega-3 fatty acids for the maintenance of health. The firm operates in the United States and Canada of which majority of the revenue is derived from the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees

Valuation

Metric
PVTTF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PVTTF
Quick Ratio
0.01
Current Ratio
0.04
Interest Coverage
−4.92
Quick Ratio
PVTTF

Profitability

Metric
PVTTF
Return on Assets (Normalized)
−224.82%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−457.54%
Return on Assets
PVTTF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHsmwnljcvyNpsm$70.0 Bil
MKKGY
Merck KGaA ADRQsztnfywgtBzbjzvr$68.1 Bil
HLN
Haleon PLC ADRXycndbtycKbglt$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMrkywqfqnZjvr$14.3 Bil
VTRS
Viatris IncSrfstqnrqSzx$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRBwkwdztbSbt$12.0 Bil
CTLT
Catalent IncSvnjjnpvfPcwhxz$10.1 Bil
PRGO
Perrigo Co PLCRnffvyxfGhwp$4.1 Bil
CURLF
Curaleaf Holdings IncBfltcqkzXhnc$3.7 Bil
PBH
Prestige Consumer Healthcare IncPxyzdvhVcfdq$3.4 Bil

Sponsor Center